Raymond James & Associates’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $137K | Buy |
+11,498
| New | +$137K | ﹤0.01% | 3701 |
|
|
2022
Q3 | – | Sell |
-101,473
| Closed | -$692K | – | 3814 |
|
|
2022
Q2 | $692K | Buy |
101,473
+10,076
| +11% | +$68.7K | ﹤0.01% | 2694 |
|
|
2022
Q1 | $1.29M | Buy |
91,397
+9,565
| +12% | +$135K | ﹤0.01% | 2420 |
|
|
2021
Q4 | $1.19M | Buy |
81,832
+5,138
| +7% | +$74.5K | ﹤0.01% | 2504 |
|
|
2021
Q3 | $1.09M | Buy |
76,694
+25,262
| +49% | +$358K | ﹤0.01% | 2524 |
|
|
2021
Q2 | $905K | Buy |
+51,432
| New | +$905K | ﹤0.01% | 2651 |
|